8JM.F VETOQUINOL INH. EO 250

Healthcare Pharmaceuticals Frankfurt Exchange
85.90 EUR
Close of Nov 11, 2026
65.30 88.50
Market cap
EUR 999M
P/E
15.8x
P/B
1.65x
ROE
9.7%
Dividend yield
1.04%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 8JM.F undervalued?

Graham number
Price85.90
Graham value79.87
Premium7.5%

8JM.F trades 7.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

VETOQUINOL INH. EO 250 fundamental analysis

No fundamental analysis for VETOQUINOL INH. EO 250 yet.

VETOQUINOL INH. EO 250 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About VETOQUINOL INH. EO 250

Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in …

Full company profile